Correlia Biosystems

Correlia Biosystems develops highly efficient protein measurements for data-driven pharma R&D, clinical trials, precision medicine and point-of-care diagnostics. PIXI platform integrates with liquid handling platforms enabling very fast (15-60 minute), multiplexed ELISAs with 2 uL sample volume capabilities, high sensitivity and broad dynamic range. Correlia’s technology enables “sample-in, data-out” simplicity, and is currently serving four of the top ten global pharma companies in applications including biomarkers, cytokines, biologics, and PK/PD studies from human, mouse or cell-based models.